ANDA 202200, held by Orbion Pharms. Levofloxacin.
As of Nov 16, 2026, ANDA 202200 (Levofloxacin), held by Orbion Pharms, was first approved by FDA on Jan 30, 2012, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 30, 2012 | Original application | Approved | None posted |
| Levofloxacin250MG · tablet;oral | Levofloxacin | Rx |
| Levofloxacin500MG · tablet;oral | Levofloxacin | Rx |
| Levofloxacin750MG · tablet;oral | Levofloxacin | Rx |
| Sep 20, 2024 | Supplement 11Labeling · Standard review | Approved | None posted |
| Feb 8, 2021 | Supplement 10Labeling · Standard review | Approved | None posted |
| Feb 8, 2021 | Supplement 9Labeling · Standard review | Approved | None posted |
| May 3, 2019 | Supplement 8Labeling · Standard review | Approved | None posted |
| Apr 26, 2019 | Supplement 7Labeling · Standard review | Approved | None posted |
| Apr 26, 2019 | Supplement 6Labeling · Standard review | Approved | None posted |
| Apr 26, 2019 | Supplement 5Labeling · Standard review | Approved | None posted |
| Apr 26, 2019 | Supplement 4Labeling · Standard review | Approved | None posted |
| Jun 24, 2016 | Supplement 3Labeling · Standard review | Approved | None posted |
| Jun 24, 2016 | Supplement 2Labeling · Standard review | Approved | None posted |
| Nov 14, 2012 | Supplement 1Labeling · Standard review | Approved | None posted |
| Jan 30, 2012 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters